HOME
>
臨床医学：外科
>
眼科学
> 専門医のための眼科診療クオリファイ　8　網膜血管障害

専門医のための眼科診療クオリファイ　8　網膜血管障害

出版社：	中山書店
著者：	大鹿哲郎大橋裕一(シリーズ総編集)白神史雄(編)
発行日：	2011-10-17
分野：	臨床医学：外科 > 眼科学
ISBN：	9784521733296
シリーズ：	専門医のための眼科診療クオリファイ
電子書籍版：	2011-10-17 （初版第1刷）

書籍・雑誌

≪全国送料無料でお届け≫

取寄せ目安：8～14営業日

14,850 円(税込)

購入する

電子書籍

章別単位での購入はできません

ブラウザ、アプリ閲覧

14,850 円(税込)

購入する

商品紹介

OCT診断と抗VEGF療法によって新しい局面を迎えつつある網膜血管障害診療。最新の大規模臨床試験などの知見も交え，発症原因別に構成。

目次

専門医のための眼科診療クオリファイ　8　網膜血管障害

―目次―

1　網膜血管の理解
　網膜血管の発生と構造
　蛍光眼底造影からみた網膜血管障害
　網膜血管障害の光干渉断層計所見

2　動脈硬化，高血圧性変化
　動脈硬化性眼底，高血圧網膜症

3　血管閉塞性疾患
　非増殖糖尿病網膜症
　増殖糖尿病網膜症
　網膜中心動脈閉塞症
　網膜中心静脈閉塞症
　網膜静脈分枝閉塞症
　眼虚血症候群
　インターフェロン網膜症

4　血管炎
　Behcet 病
　サルコイドーシス
　結核
　Eales病
　全身性エリテマトーデス
　急性網膜壊死
　樹氷状血管炎

5　血管拡張性疾患
　Coats 病
　黄斑部毛細血管拡張症
　網膜細動脈瘤
　Leber 粟粒血管腫症

6　腫瘍性疾患
　網膜血管腫

7　発達障害
　未熟児網膜症
　家族性滲出性硝子体網膜症

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1 網膜血管の理解

P.8 掲載の参考文献

i 丸尾敏夫ら : 蛍光眼底造影法. 眼科学. 東京 : 文光堂 ; 2002. p.870-875.

P.17 掲載の参考文献

1 Otani T, et al : Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 1999 ; 127 : 688-693.

2 Otani T, et al : Correlation between optical coherence tomography and fluorescein angiography findings in diabetic macular edema. Ophthalmology 2007 ; 114 : 104-107.

3 Bolz M, et al : Optical coherence tomographic hyperreflective foci : a morphologic sign of lipid extravasation in diabetic macular edema. Ophthalmology 2009 ; 116 : 914-920.

4 Otani T, et al : Correlation between visual acuity and foveal microstructural changes in diabetic macular edema. Retina 2010 ; 30 : 774-780.

5 Sakamoto A, et al : Association between foveal photoreceptor status and visual acuity after resolution of diabetic macular edema by pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol 2009 ; 247 : 1325-1330.

6 Otani T, et al : Serous macular detachment secondary to distant retinal vascular disorders. Retina 2004 ; 24 : 758-762.

7 Yannuzzi LA, et al : Idiopathic macular telangiectasia. Arch Ophthalmol 2006 ; 124 : 450-460.

3 血管閉塞性疾患

P.40 掲載の参考文献

1 Davis MD, et al : Natural evolution. In : L' Esperance FA Jr, ed. Current diagnosis and management of choroidal diseases. Saint Louis : CV Mosby ; 1977. p179-184.

2 福田雅俊 : 糖尿病網膜症の病期分類. 堀貞夫編. 眼科MOOK 46 糖尿病と眼科診療. 東京 : 金原出版 ; 1991. p.117-125.

3 CP Wilkinson, et al : Proposed International Clinical Diabetic Retinopathy and Diabetic Macular Edema Disease Severity Scales. Ophthalmology 2003 ; 110 : 1677-1682.

4 The Diabetes Control and Complications Trial Research Group : Early Worsening of Diabetic Retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol 1998 ; 116 : 874-886.

5 眼底血管造影実施基準 (改訂版). 日本眼科学会雑誌 2011 ; 115 : 67-75.

6 清水弘一 : 分担研究報告書汎網膜光凝固治療による脈絡膜循環の変化と糖尿病血管新生緑内障のレーザー治療ならびに糖尿病網膜症の光凝固適応及び実施基準. 平成6年度糖尿病調査研究報告書. 厚生省 : 1995. p.346-349.

7 佐藤幸裕ら : 糖尿病網膜症に対する網膜光凝固の適正化に関する多施設無作為臨床試験. 日本眼科学会雑誌 2010 ; 114 : 215.

P.45 掲載の参考文献

1 Saaddine JB, et al : Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus : United States, 2005-2050. Arch Ophthalmol 2008 ; 126 : 1740-1747.

2 The Diabetes Control Complications Trial Research Group : Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol 1998 ; 116 : 874-886.

3 Chaturvedi N, et al : Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet 1998 ; 351 : 28-31.

4 福本雅格ら : 重症糖尿病網膜症における硝子体手術前の硝子体手術前の汎網膜光凝固の効果. 日本眼科学会雑誌 2009 ; 113 : 901-905.

5 Avery RL, et al : Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006 ; 113 : 1695. e1-15.

P.52 掲載の参考文献

1 Katsuki S, et al : Recent trends in incidence of cerebral hemorrhage and infarction in Japan. A report based on death rates, autopsy case and prospective study on cerebrovascular disease. Jpn heart J 1966 ; 7 : 26-34.

2 Miyazaki M, et al : Comparison of diagnostic methods for diabetes mellitus based on prevalence of retinopathy in a Japanese population : the Hisayama Study. Diabetologia 2004 ; 47 : 1411-1415.

3 Kawasaki R, et al : Impaired glucose tolerance, but not impaired fasting glucose, is associated with retinopathy in Japanese population : the Funagata study. Diabetes Obes Metab 2008 ; 10 : 646-651.

P.57 掲載の参考文献

1 Klein R, et al : The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984 ; 102 : 520-526.

2 Klein R, et al : The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984 ; 102 : 527-532.

3 Ohkubo Y, et al : Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus : a randomized prospective 6-year study. Diabetes Res Clin Pract 1995 ; 28 : 103-117.

4 曽根博仁ら : 糖尿病網膜症一次予防および二次予防のエビデンス-他の合併症との関連ならびにJDCS中間報告から. あたらしい眼科 2007 ; 24 : 1281-1285.

P.61 掲載の参考文献

1 Diabetic Retinopathy Clinical Research Network, Elman MJ, et al : Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010 ; 117 : 1064-1077.

P.65 掲載の参考文献

1 Jain A, et al : Effect of pulse duration on size and character of the lesion in retinal photocoagulation. Arch Ophthalmol 2008 ; 126 : 78-85.

2 Al-Hussainy S, et al : Pan response and follow-up of patients undergoing panretinal laser photocoagulation with reduced exposure times. Eye 2008 ; 22 : 96-99.

3 The Manchester Pascal Study : Single-session vs multiple-session pattern scanning laser panretinal photocoagulation in proliferative diabetic retinopathy. Arch Ophthalmol 2010 ; 128 : 525-533.

4 Shimura M, et al : Combination therapy for retinal vein occlusion. Ophthalmology 2010 ; 117 : 1858. e1-3.

5 Shimura M, et al : Pretreatment of posterior subtenon injection of triamcinolone acetonide has beneficial effects for grid pattern photocoagulation against diffuse diabetic macular edema. Br J Ophthalmol 2007 ; 91 : 449-454.

P.71 掲載の参考文献

1 Noma H, et al : Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion. Ophthalmology 2009 ; 116 : 87-93.

2 Noma H, et al : Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2006 ; 244 : 309-315.

3 CATT Research Group, et al : Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 2011 ; 364 : 1897-1908.

4 Aiello LP, et al : Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994 ; 331 : 1480-1487.

5 Arevalo JF, et al : Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol 2008 ; 92 : 213-216.

6 Yamaji H, et al : Reduction in dose of intravitreous bevacizumab before vitrectomy for proliferative diabetic retinopathy. Arch Ophthalmol 2011 ; 129 : 106-107.

7 Ueta T, et al : Cerebrovascular accidents in ranibizumab. Ophthalmology 2009 ; 116 : 362.

P.77 掲載の参考文献

1 Hayreh SS, et al : Central retinal artery occlusion and retinal tolerance time. Ophthalmology 1980 ; 87 : 75-78.

2 張野正誉 : 網膜動脈閉塞症. 眼科診療プラクティス 85 血管閉塞性疾患の診療. 東京 : 文光堂 ; 2002. p.38-41.

3 上田美子ら : 視力良好な網膜中心動脈閉塞症の1例. 眼科 2009 ; 51 : 443-446.

4 Sharma S, et al : Retinal artery obstruction. In : Ryan SJ, editors. Retina. 4th ed. Philadelphia : Elsevier Mosby ; 2006.

5 Kurimoto T, et al : Central retinal artery occlusion resembling Purtscher-like retinopathy. Clin Ophthalmol 2011 ; 5 : 1083-1088.

6 須藤勝也ら : 網膜中心動脈閉塞症の網膜断層像. 臨床眼科 2001 ; 55 : 905-908.

P.83 掲載の参考文献

i Hayreh SS, et al : Differentiation of ischemic from non-ischemic central retinal vein occlusion during the early acute phase. Graefes Arch Clin Exp Ophthalmol 1990 ; 228 : 201-217.

ii The Central Vein Occlusion Study Group : Baseline and early natural history report. Arch Ophthalmol 1993 ; 111 : 1087-1195.

iii The Central Vein Occlusion Study Group : Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. M report. Ophthalmology 1995 ; 102 : 1425-1433.

iv The Central Vein Occlusion Study Group : A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. N report. Ophthalmology 1995 ; 102 : 1434-1444.

v McIntosh RL, et al : Natural history of central retinal vein occlusion : an evidence-based systematic review. Ophthalmology 2010 ; 117 : 1113-1123.

vi Hayreh SS, et al : Natural history of visual outcome in central retinal vein occlusion. Ophthalmology 2011 ; 118 : 119-133.

P.89 掲載の参考文献

1 Natural history and clinical management of central retinal vein occlusion. The central retinal vein occlusion study group. Arch Ophthalmol 1997 ; 115 : 486-491.

2 The central vein occlusion study group M report. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. Ophthalmology 1995 ; 102 : 1425-1433.

P.92 掲載の参考文献

1 Aref AA, et al : Management of macular edema secondary to central retinal vein occlusion : an evidence-based. Adv Ther 2011 ; 28 : 40-50.

2 Brown DM, et al : Ranibizumab for macular edema following central retinal vein occlusion : six-month primary end point results of a phase III study. Ophthalmology 2010 ; 117 : 1124-1133.

3 The SCORE Study Research Group : A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion : the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol 2009 ; 127 : 1101-1114.

4 Haller JA, et al : Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010 ; 117 : 1134-1146.

5 Kondo M, et al : Intravitreal bevacizumab (Avastin) for persistent macular edema in vitrectomized eyes : Limited effect and early recurrence. Retin Cases Brief Rep 2007 ; 1 : 195-197.

6 Yasuda S, et al : Significant correlation between electroretinogram parameters and ocular vascular endothelial growth factor concentration in central retinal vein occlusion eyes. Invest Ophthalmol Vis Sci 2011 ; 52 : 5737-5742.

7 The Central Vein Occlusion Study Group : Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. Ophthalmology 1995 ; 102 : 1425-1433.

P.105 掲載の参考文献

1 The Branch Vein Occlusion Study Group : Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 1984 ; 98 : 271-282.

2 綾木雅彦ら : 網膜静脈分枝閉塞症の自然経過と視力予後. 臨床眼科 1985 ; 39 : 1347-1351.

3 Shroff D, et al : Natural history of macular status in recent-onset branch retinal vein occlusion : an optical coherence tomography study. Int Ophthalmol 2008 ; 28 : 261-268.

4 Finkelstein D : Ischemic macular edema. Recognition and favorable natural history in branch vein occlusion. Arch Ophthalmol 1992 ; 110 : 1427-1434.

5 Klein R, et al : The 15-year cumulative incidence of retinal vein occlusion : the Beaver Dam Eye Study. Arch Ophthalmol 2008 ; 126 : 513-518.

6 Cugati S, et al : Ten-year incidence of retinal vein occlusion in an older population : the Blue Mountains Eye Study. Arch Ophthalmol 2006 ; 124 : 726-732.

7 Yasuda M, et al : Prevalence and systemic risk factors for retinal vein occlusion in a general Japanese population : the Hisayama study. Invest Ophthalmol Vis Sci 2010 ; 51 : 3205-3209.

8 Arakawa S, et al : Nine-year incidence and risk factors for retinal vein occlusion in a general Japanese population : the Hisayama Study. Invest Ophthalmol Vis Sci 2011 ; 52 : 5905-5909.

P.109 掲載の参考文献

1 Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) Study home page. https://web.emmes.com/study/score/

2 SCORE Study Research Group : A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion : the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 5. Arch Ophthalmol 2009 ; 127 : 1101-1114.

3 SCORE Study Research Group : A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion : the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 6. Arch Ophthalmol 2009 ; 127 : 1115-1128.

4 The Central Vein Occlusion Study Group : Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion : the Central Vein Occlusion Study Group M report. Ophthalmology 1995 ; 102 : 1425-1433.

109-5 Mohamed Q, et al : Interventions for central retinal vein occlusion. Ophthalmology 2007 ; 114 : 507-519, 524.

6 Scott IU, et al ; SCORE Study Investigator Group : SCORE Study Report 1 : baseline association between central retinal thickness and visual acuity in patients with retinal vein occlusion. Ophthalmology 2009 ; 116 : 504-512.

7 Scott IU, et al ; Standard Care versus COrticosteroid for REtinal Vein Occlusion Study Investigator Group : Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion : Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10. Ophthalmology 2011 ; 118 : 345-352.

8 The Branch Vein Occlusion Study Group : Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 1984 ; 98 : 271-282.

P.113 掲載の参考文献

1 Rabena MD, et al : Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina 2007 ; 27 : 419-425.

2 Matsumoto Y, et al : Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease. Retina 2007 ; 27 : 426-431.

3 Shroff D, et al : Natural history of macular status in recent-onset branch retinal vein occlusion : an optical coherence tomography study. Int Ophthalmol 2008 ; 28 : 261-268.

4 Mandelcorn MS, et al : Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion : a report of 14 cases. Retina 2004 ; 24 : 348-355.

P.117 掲載の参考文献

1 Brown GC, et al : The ocular ischemic syndrome : clinical, fluorescein angiographic and carotid angiographic features. Int Ophthalmol 1988 ; 11 : 239-251.

2 Dugan JD Jr., et al : Ophthalmologic manifestations of carotid occlusive disease. Eye 1991 ; 5 : 226-238.

3 Mendrinos E, et al : Ocular ischemic syndrome. Surv Ophthalmol 2010 ; 55 : 2-34.

4 Sivalingham A, et al : The ocular ischemic syndrome. III. Visual prognosis and the effect of treatment. Int Ophthalmol 1991 ; 15 : 15-20.

P.123 掲載の参考文献

1 池辺徹ら : インターフェロン投与中に視力障害をきたした1例. 日本眼科紀要 1990 ; 41 : 2291-2296.

2 Hayasaka et al : Interferon associated retinopathy. Br J Ophthalmol 1998 ; 82 : 323-325.

3 宗司西美ら : C型慢性活動性肝炎治療時にみられるインターフェロン網膜症の危険因子の検討. 日本眼科学会雑誌 1996 ; 100 : 69-76.

4 Nishiwaki H, et al : Interferon alfa induces leukocyte capillary trapping in rat retinal microcirculation. Arch Ophthalmol 1996 ; 114 : 726-730.

4 血管炎

P.130 掲載の参考文献

1 Meguro A, et al : Genetics of Behcet's disease inside and outside the MHC. Ann Rheum Dis 2010 ; 69 : 747-754.

2 Ohno S, et al : Close association of HLA-Bw51 with Behcet's disease. Arch Ophthalmol 1982 ; 100 : 1455-1458.

3 Yokota K, et al : Characterization of Streptococcus sanguis isolated from patients with Behcet's disease. Microbiol Immunol 1995 ; 39 : 729-732.

P.137 掲載の参考文献

1 Matsumura N, et al : Leukocyte movement and colchicine treatment in Behcet's disease. Lancet 1975 ; 2 : 813.

2 Ohno S, et al : Efficacy, Safety, and Pharmacokinetics of multiple administration of infliximab in Behcet's disease with refractory uveoretinitis. J Rheumatol 2004 ; 31 : 1362-1368.

3 Masuda K, et al : Double-masked trial of cyclosporin versus colchicin and long-term open study of cyclosporin in Behcet's disease. Lancet 1989 ; 1 : 1093-1096.

4 Mishima S, et al : Behcet's disease in Japan-Ophthalmologic aspect. The eighth Frederick H. Verhoeff lecture. Trans Am Ophthalmol Soc 1979 ; 77 : 225-279.

5 Ohguro N, et al : Repeated intravitreal triamcinolone injections in Behcet's disease resistant to conventional therapy. One year results Am J Ophthalmol 2006 ; 141 : 218-220.

P.141 掲載の参考文献

1 Rothova A : Ocular involvement in sarcoidosis. Br J Ophthalmol 2000 ; 84 : 110-116.

2 Kawaguchi T, et al : Evalation of characteristics ocular sign and systemic investigations in ocular sarcoidosis patients. Jpn J Ophthalmol 2007 ; 51 : 121-126.

3 Ishige I, et al : Quatitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese petients with sarcoidodis. Lancet 1999 ; 354 : 120-123.

4 Popper HH : Epithelioid cell granulomatosis of the lung ; new insights and concept. Sarcoidodis Vasculitis and Diffuse Lung Diseases 1999 ; 16 : 32-46.

5 Chan CC, et al : Immunohistopathology of ocular sarcoidosis. Report of a case and discussion of immunopathogenesis. Arch Ophthalmol 1987 ; 105 : 1398-1402.

6 Palmer HE, et al : Non-caseating granulomas as a case of ischemic retinal vasculitis. Br J Ophthalmol 1997 ; 81 : 1018-1019.

7 Gass JDM, et al : Sarcoidosis with optic nerve and retinal involvement. Arch Ophthalmol 1976 ; 94 : 945-950.

8 Verougstraete C, et al : Multiple arterial ectasias in patients with sarcoidosis and uveitis. Am J Ophthalmol 2001 ; 131 : 223-231.

P.146 掲載の参考文献

1 結核研究所疫学情報センター : 結核年報 2008 Series 1. 結核発生動向速報. 結核 2009 ; 84 : 693-696.

2 WHO : Global Tuberculosis Control 2009. 2009.

3 Carnona L, et al : Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rhem 2005 ; 52 : 1766-1772.

4 齋藤航 : 結核. 臨床眼科 2007 ; 61 : 210-215.

5 青木正和 : 結核は今-現状と問題点. 肺外結核. 臨牀と研究 2007 ; 84 : 542-545.

6 Keino H, et al : Frequency and clinical features of intraocular inflammation in Tokyo. Clin Experiment Ophthalmol 2009 ; 37 : 595-601.

7 Tabbara KF : Tuberculosis. Cur Opin Ophthalmol 2007 ; 18 : 493-501.

8 後藤浩 : 結核性ぶどう膜炎の現状と診断, 治療上の問題点. 日本眼科紀要 2001 ; 52 : 461-467.

9 Morimura Y, et al : Tuberculin skin testing in uveitis patients and treatment of presumed intraocular tuberculosis in Japan. Ophthalmology 2002 ; 109 : 851-857.

10 Ang M, et al : Diagnosis of tuberculosis uveiti : clinical application of an interferon-gamma release assay. Ophthalmology 2009 ; 116 : 1391-1396.

11 Cheng CM, et al : Jarisch-Herxheimer reaction : paradoxical worsening of tuberculosis chorioretinaitis following initiation of antituberculous therapy. Eye 2009 ; 23 : 1472-1473.

P.157 掲載の参考文献

1 Mills JA : Systemic lupus erythematosus. N Engl J Med 1994 ; 330 : 1871-1879.

2 Arevalo JF, et al : Ocular manifestations of systemic lupus erythematosus. Curr Opin Ophthalmol 2002 ; 13 : 404-410.

3 Davies JB, et al : Ocular manifestations of systemic lupus erythematosus. Curr Opin Ophthalmol 2008 ; 19 : 512-518.

4 Snyers B, et al : Retinal and choroidal vaso-occlusive disease in systemic lupus erythematosus associated with antiphospholipid antibodies. Retina 1990 ; 10 : 255-260.

5 山田浩喜ら : ステロイドの大量療法が無効であった全身性エリテマトーデスに伴う漿液性網膜剥離の1例. 臨床眼科 2007 ; 61 : 847-851.

6 Giorgi D, et al : Retinopathy in systemic lupus erythematosus : pathogenesis and approach to therapy. Hum Immunol 1999 ; 60 : 688-696.

P.165 掲載の参考文献

1 伊藤康行ら : 樹氷状血管炎を呈した小児ブドウ膜炎. 臨床眼科 1976 ; 30 : 797-803.

2 Watanabe Y, et al : A case of frosted branch angiitis. Br J Ophthalmol 1987 ; 71 : 553-558.

3 沖波聡ら : 樹氷状血管炎の4例. 日本眼科紀要 1994 ; 45 : 314-318.

4 柿丸昌子ら : ステロイドパルス療法が奏功した片眼性樹氷状血管炎の小児例. 臨床眼科1998 ; 92 : 22-25.

5 松田吉人ら : 著明な網膜および脈絡膜の循環障害を認めた樹氷状血管炎の1例. 臨床眼科 2000 ; 54 : 1287-1291.

6 柳橋まどから : 高度の閉塞性血管炎を合併した樹氷状血管炎の1例. 臨床眼科 2008 ; 62 : 1297-1301.

7 山崎哲ら : インフルエンザウイルスの関与が疑われた樹氷状血管炎の1例. あたらしい眼科 2005 ; 22 : 397-401.

8 南政宏ら : アレルギー性紫斑病を合併した樹氷状血管炎の1例. 臨床眼科 1997 ; 51 : 949-952.

9 山形忍ら : 溶連菌感染症が疑われた樹氷状血管炎の1例. あたらしい眼科 1995 ; 12 : 1317-1321.

10 Kleiner RC, et al : Acute frosted retinal periphlebitis. Am J Ophthalmol 1988 ; 106 : 27-34.

5 血管拡張性疾患

P.170 掲載の参考文献

1 Meyer-Schwickerath G : Lichtkoagulation : Bucherei des Augenarztes. Beiheft Klin Mbl Augenheilk 1959 ; 33 : 6.

2 Ridley ME, et al : Coats' disease : Evaluation of management. Ophthalmology 1982 ; 89 : 1381-1387.

3 Spitznas M, et al : Treatment of Coats' disease with photocoagulation. Albrecht V. Graefes Arch Klin Exp Ophthalmol 1976 ; 199 : 31-37.

4 桂弘ら : コーツ病 : 治療効果の検討. 臨床眼科 1984 ; 38 : 287-291.

5 Fox KR : Coats' disease. Metab Pediat Ophthalmol 1980 : 4 : 121-124.

6 Machemer R, et al : Pathogenesis and therapy of traction detachment in various retinal vascular diseases. Am J Ophthalmol 1988 ; 105 : 170-181.

7 井上真ら : コーツ病に対する硝子体手術の経験. 日本眼科学会雑誌 1996 ; 100 : 358-362.

8 Stergiou PK, et al : Coats' disease : treatment with intravitreal bevacizumab and laser photocoagulation. Acta Ophthalmol 2009 ; 87 : 687-688.

P.175 掲載の参考文献

1 Stergiou PK, et al : Coats' disease : treatment with intravitreal bevacizumab and laser photocoagulation. Acta Ophthalmol 2009 ; 87 : 687-688.

2 Alvarez-Rivera LG, et al : Coat's disease treated with bevacizumab (Avastin). Arch Soc Esp Oftalmol 2008 ; 83 : 329-331.

3 Cackett P, et al : Combined intravitreal bevacizumab and argon laser treatment for Coats' disease. Acta Ophthalmol 2010 ; 88 : 48-49.

4 Kaul S, et al : Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of Coats' disease in children. Indian J Ophthalmol 2010 ; 58 : 76-78.

5 Sun Y, et al : Elevated vascular endothelial growth factor levels in Coats disease : rapid response to pegaptanib sodium. Graefes Arch Clin Exp Ophthalmol 2007 ; 245 : 1387-1388.

P.178 掲載の参考文献

1 Gass JD, et al : Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study. Ophthalmology 1993 ; 100 : 1536-1546.

2 Gass JDM : Stereoscopic atlas of macular diseases diagnosis and treatment, 4th ed. Vol. 1. St. Louis : CV Mosby ; 1997. p.504-511.

3 Yannuzzi LA, et al : Idiopathic macular telangiectasia. Arch Ophthalmol 2006 ; 124 : 450-460.

4 Hirano Y, et al : Indocyanine green angiography-guided laser photocoagulation combined with sub-Tenon's capsule injection of triamcinolone acetonide for idiopathic macular telangiectasia. Br J Ophthalmol 2010 ; 94 : 600-605.

5 Maruko I, et al : Early morphological changes and functional abnormalities in group 2A idiopathic juxtafoveolar retinal telangiectasis using spectral domain optical coherence tomography and microperimetry. Br J Ophthalmol 2008 ; 92 : 1488-1491.

6 Koizumi H, et al : Morphologic features of group 2A idiopathic juxtafoveolar retinal telangiectasis in three-dimensional optical coherence tomography. Am J Ophthalmol 2006 ; 142 : 340-343.

7 Gaudric A, et al : Optical coherence tomography in group 2A idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol 2006 ; 124 : 1410-1419.

8 Charbel Issa P, et al : Confocal blue reflectance imaging in type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci 2008 ; 49 : 1172-1177.

9 Wong WT, et al : Fundus autofluorescence in type 2 idiopathic macular telangiectasia : correlation with optical coherence tomography and microperimetry. Am J Ophthalmol 2009 ; 148 : 573-583.

10 Helb HM, et al : Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia. Retina 2008 ; 28 : 808-816.

11 Park DW, et al : Grid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasis. Ophthalmology 1997 ; 104 : 1838-1846.

12 Charbel Issa P, et al : Monthly ranibizumab for nonproliferative macular telangiectasia type 2 : a 12-month prospective study. Am J Ophthalmol 2011 ; 151 : 876-886.

13 Potter MJ, et al : Photodynamic therapy of a subretinal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis. Am J Ophthalmol 2002 ; 133 : 149-151.

14 Konstantinidis L, et al : Intravitreal ranibizumab as primary treatment for neovascular membrane associated with idiopathic juxtafoveal retinal telangiectasia. Graefes Arch Clin Exp Ophthalmol 2009 ; 247 : 1567-1569.

15 Rishi P, et al : Combined photodynamic therapy and intravitreal ranibizumab as primary treatment for subretinal neovascular membrane (SRNVM) associated with type 2 idiopathic macular telangiectasia. Graefes Arch Clin Exp Ophthalmol 2008 ; 246 : 619-621.

16 Aung KZ, et al : The prevalence estimates of macular telangiectasia type 2 : the Melbourne Collaborative Cohort Study. Retina 2010 ; 30 : 473-478.

17 Klein R, et al : The prevalence of macular telangiectasia type 2 in the Beaver Dam eye study. Am J Ophthalmol 2010 ; 150 : 55-62.

18 Maruko I, et al : Demographic features of idiopathic macular telangiectasia in Japanese patients. Jpn J Ophthalmol (in press)

19 Barbazetto IA, et al : ATM gene variants in patients with idiopathic perifoveal telangiectasia. Invest Ophthalmol Vis Sci 2008 ; 49 : 3806-3811.

P.186 掲載の参考文献

1 Gass JD, et al : Idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol 1982 ; 100 : 769-780.

2 Gass JD, et al : Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study. Ophthalmology 1993 ; 100 : 1536-1546.

3 Yannuzzi LA, et al : Idiopathic macular telangiectasia. Arch Ophthalmol 2006 ; 124 : 450-460.

4 Hirano Y, et al : Indocyanine green angiography-guided laser photocoagulation combined with sub-tenon's capsule injection of triamcinolone acetonide for idiopathic macular telangiectasia. Br J Ophthalmol 2010 ; 94 : 600-605.

5 Charbel Issa P, et al : Eighteen-month follow-up of intravitreal bevacizumab in type 2 idiopathic macular telangiectaia. Br J Ophthalmol 2008 ; 92 : 941-945.

6 Potter MJ, et al : Photodynamic therapy for subretinal neovascularization in type 2A idiopathic juxtafoveolar telangiectasis. Can J Ophthalmol 2006 ; 41 : 34-37.

7 Mandal S, et al : Intravitreal bevacizumab (Avastin) for the subretinal neovascularization secondary to type 2A idiopathic juxtafoveal telangiectasia. Graefes Arch Clin Exp Ophthalmol 2007 ; 245 : 1825-1829.

8 Rishi P, et al : Combined photodynamic therapy and intravitreal ranibizumab as primary treatment for subretinal neovascular membrane (SRNVM) associated with type 2 idiopathic macular telangiectasia. Graefes Arch Clin Exp Ophthalmol 2008 ; 246 : 619-621.

P.191 掲載の参考文献

i Chew EY, et al : Acquired retinal macroaneurysms. In : Ryan SJ, et al, editors. Retina. 4th ed. St Louis : Mosby ; 2005. p.1500-1504.

ii Schneider U, et al : Indocyanine green videoangiography of hemorrhagic retinal macroaneurysms. Ophthalmologica 1997 ; 211 : 115-118.

iii Ohji M, et al : Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator. Arch Ophthalmol 1988 ; 116 : 1326-1332.

iv Rabb MF, et al : Retinal arterial macroaneurysms. Sur Ophthalmol 1988 ; 33 : 73-96.

v Abdel-Khalek MN, et al : Retinal macroaneurysm : natural history and guidelines for treatment. Br J Ophthalmol 1986 ; 70 : 2-11.

vi Chanana B, et al : Intravitreal bevacizumab for macular edema secondary to retinal macroaneurysm. Eye 2009 ; 23 : 493-494.

vii Wenkstem AR, et al : Intravitreal ranibizumab in retinal macroaneurysm. Graefes Arch Clin Exp Ophthalmol 2010 ; 248 : 1167-1170.

P.195 掲載の参考文献

1 Ulbig MW, et al : Long-term results after drainage of premacular subhyaloid hemorrhage into the vitreous with a pulsed Nd : YAG laser. Arch Ophthalmol 1998 ; 116 : 1465-1469.

2 O'Hanley GP, et al : Diabetic dense premacular hemorrhage. A possible indication for prompt vitrectomy. Ophthalmology 1985 ; 92 : 507-511.

3 Clearly PE, et al : Retinal macroaneurysms. Br J Ophthalmol 1975 ; 59 : 355-361.

4 池田恒彦ら : Nd-YAGレーザーによる網膜前出血の治療. 眼科 32 : 1327-1331.

5 Lewis H, et al : Tissue plasminogen activator treatment of experimental subretinal hemorrhage. Am J Ophthalmol 1991 ; 111 : 197-204.

6 Ohji M, et al : Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator. Arch Ophthalmol 1998 ; 116 : 1326-1332.

7 Heriot WJ : Intravitreal gas and tPA : an out patient procedure for submacular hemorrage. Paper presented at ; American Academy of Ophthalmology Annual Vitreoretinal Update ; October 1996 ; Chicago, III.

8 Hassan AS, et al : Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology 1999 ; 106 : 1900-1906.

9 banez HE, et al : Surgical management of submacular hemorrhage. A series of 47 consecutive cases. Arch Ophthalmol 1995 ; 113 : 62-69.

10 Kamei M, et al : Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid. Am J Ophthalmol 1996 ; 121 : 267-275.

P.198 掲載の参考文献

1 Do DV, et al : Coats' Disease. In: Ryan SJ, editor. retina. 4 ed. Philadelphia : Elsevier ; 2006. p.1417-1423.

2 Destro M, et al : Coats' disease and retinal telangiectasia. In : Albert DM, et al, editors. Principles and practice of ophthalmology. Philadelphia : WB Saunders ; 2000. p.1957-1965.

3 Reese AB : Telangiectasis of the retina and Coats' disease. Am J Ophthalmol 1956 : 42 : 1-8.

4 Gass JDM : Primary or congenital retinal telangiectasis (Leber's miliary aneurysms, Coats' sydrome). Stereoscopic atlas of macular diseases, diagnosis and treatment. St. Luis : Mosby, 1997. v. 1.

5 野村昌弘ら : レーベル粟粒血管瘤に対する治療成績. 臨床眼科 1994 ; 48 : 652-654.

6 腫瘍性疾患

P.204 掲載の参考文献

1 Singh AD, et al : Retinal capillary hemangioma : a comparison of sporadic cases and cases associated with von Hippel-Lindau disease. Ophthalmology 2001 ; 108 : 1907-1911.

2 Shields JA, et al : Presumed acquired retinal hemangiomas. Ophthalmology 1983 ; 90 : 1292-1300.

3 Shields CL, et al : Vasoproliferative tumors of the ocular fundus. Arch Ophthalmol 1995 ; 113 : 615-623.

4 Reddy S, et al : Novel KRIT1/CCM1 mutation in a patient with retinal cavernous hemangioma and cerebral cavernous malformation. Graefes Arch Clin Exp Ophthalmol 2010 ; 248 : 1359-1361.

5 Blasi MA, et al : Photodynamic therapy for vasoproliferative retinal tumors. Retina 2006 ; 26 : 404-409.

7 発達障害

P.210 掲載の参考文献

1 Terry TL : Fibroblastic overgrowth of persistent tunica vasculosa lentis in infants born prematurely : Report of cases-clinical aspects. Trans Am Ophthalmol Soc 1942 ; 40 : 262-284.

2 Gilbert C : Changing challenges in the control of blindness in children. Eye 2007 ; 21 : 1338-1343.

3 International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005 ; 123 : 991-999.

4 Tlucek PS, et al : Effect of decreasing target oxygen saturation on retinopathy of prematurity. J AAPOS 2010 ; 14 : 406-411.

5 SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Target Ranges of Oxygen Saturation in Extremely Preterm Infants. N Engl J Med 2010 ; 362 : 1959-1969.

6 Tarnow-Mordi WO, et al : Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med 2010 ; 363 : 1285 ; author reply 1285-1286.

7 Kusaka S, et al : Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity : a pilot study. Br J Ophthalmol 2008 ; 92 : 1450-1455.

8 Mintz-Hittner HA, et al : Intravitreal injection of bevacizumab (avastin(R)) for treatment of Stage 3 retinopathy of prematurity in Zone I or posterior Zone II. Retina 2008 ; 28 : 831-838.

9 Mintz-Hittner HA, et al : BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for Stage 3+ retinopathy of prematurity. N Engl J Med 2011 ; 364 : 603-615.

10 Moshfeghi DM, et al : Retinopathy of Prematurity in the Time of Bevacizumab : Incorporating the BEAT-ROP Results into Clinical Practice. Ophthalmology 2011 ; 7 : 1227-1228.

P.216 掲載の参考文献

1 Schaffer DB, et al : Prognostic factors in the natural course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 1993 ; 100 : 230-237.

2 Reynolds JD, et al : CRYO-ROP and LIGHT-ROP Cooperative Study Groups. Evidence-based screening criteria for retinopathy of prematurity : natural history data from the CRYO-ROP and LIGHT-ROP studies. Arch Ophthalmol 2002 ; 120 : 1470-1476.

3 Early Treatment for Retinopathy of Prematurity Cooperative Group : Revised indications for the treatment of retinopathy of prematurity : results of the Early Treatment for Retinopathy of Prematurity Randomised Trial. Arch Ophthalmol 2003 ; 121 : 1684-1694.

4 Kivlin JD, et al : Early retinal vessel development and iris vessel dilatation as factors in retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) Cooperative Group. Arch Ophthalmol 1996 ; 114 : 150-154.

5 Brown DR, et al : Retinopathy of prematurity : the relationship with intraventricular hemorrhage and bronchopulmonary dysplasia. J Pediatr Ophthalmol Strabismus 1990 ; 27 : 268-271.

6 Reynolds JD, et al : Lack of efficacy of light reduction in preventing retinopathy of prematurity. Light Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative Group. N Engl J Med 1998 ; 338 : 1572-1576.

7 McGrath JM : Supplemental oxygen did not reduce progression of pre-threshold retinopathy of prematurity in infants. commentary on The STOP-ROP Multicenter Study Group. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity STOP-ROP, a randomized, controlled trial. I : Primary outcomes. Pediatrics 2000 ; 105 : 295-310.

P.218 掲載の参考文献

1 An International Committee for the Classification of Retinopathy of Prematurity : The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005 ; 123 : 991-999.

2 Early Treatment for Retinopathy of Prematurity Cooperative Group : Revised indications for the treatment of retinopathy of prematurity. Results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 2003 ; 121 : 1684-1696.

3 Quinn GE, et al : Progression of myopia and high myopia in the early treatment for retinopathy of prematurity study. Findings to 3 years of age. Ophthalmology 2008 ; 115 : 1058-1064.

4 Christiansen SP, et al : Cataract in infants treated with argon laser photocoagulation for threshold retinopathy of prematurity. Am J Ophthalmol 1995 ; 119 : 175-180.

5 Trigler L, et al : Case series of angle-closure glaucoma after laser treatment for retinopathy of prematurity. JAAPOS 2005 ; 9 : 17-21.

6 Tufail A, et al : Late onset vitreoretinal complications of regressed retinopathy of prematurity. Br J Ophthalmol 2004 ; 88 : 243-246.

P.222 掲載の参考文献

1 Trese MT, et al : Scleral buckling for retinopathy of prematurity. Ophthalmology 1994 ; 101 : 23-26.

2 Seaber JH, et al : Long-term visual results of children after initially successful vitrectomy for Stage V retinopathy of prematurity. Ophthalmology 1995 ; 102 : 199-204.

3 Capone A Jr., et al : Lens-sparing vitreous surgery for tractional Stage 4A retinopathy of prematurity retinal detachments. Ophthalmology 2001 ; 108 : 2068-2070.

4 Azuma N, et al : Early vitreous surgery for aggressive posterior retinopathy of prematurity. Am J Ophthalmol 2006 ; 142 : 636-643.

5 Prenner JL, et al : Visual outcomes after lens-sparing vitrectomy for Stage 4A retinopathy of prematurity. Ophthalmology 2004 ; 111 : 2271-2273.

6 Kusaka S, et al : Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity : a pilot study. Br J Ophthalmol 2008 ; 92 : 1450-1455.

P.234 掲載の参考文献

i 有田直子ら : 出生後早期に光凝固治療を行った家族性滲出性硝子体網膜症. 眼科臨床医報 2006 ; 100 : 49-51.

書評

書評を投稿する

最近チェックした商品履歴

Loading...